The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for Chemotherapy

Completed · Not applicable

Conditions studied: Stem Cell Transplantation, Hematopoietic

In brief

The purpose of this randomized trial will evaluate whether providing clinicians with daily reports from a well-validated, standardized, patient-centered electronic symptom survey tool (PRO-CTCAE) improves symptom burden in patients undergoing high-dose chemotherapy. Adult inpatients at UNC undergoing high-dose chemotherapy for preparative chemotherapy prior to stem cell infusion. Participants will be randomized into one of two arms: (1) a control arm with standard of care daily clinician interviews or (2) standard of care plus daily electronic symptom surveys, the results of which will be sent to clinicians electronically.

Key facts

Study ID

NCT02574897

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

76

Starts

2014-07-01

Expected to finish

2017-09-01

Last updated by the study team

2018-03-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Verification of access to a functioning email account
• >= 18 years of age
• <= 75 years of age
• Able to read in English
• Assessed as competent based on discretion of study personnel
• Willing and able to provide signed, informed consent

You may not qualify if…

• Concurrent participation in LCCC1234

Where it is running

• Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.